Literature DB >> 19819721

Cytokine expression in placenta-derived mesenchymal stem cells in patients with pre-eclampsia and normal pregnancies.

Jong Ha Hwang1, Mi Jung Lee, Oye Sun Seok, Yu Chin Paek, Geum Joon Cho, Hyun Joo Seol, Jae Kwan Lee, Min Jeong Oh.   

Abstract

OBJECTIVES: The aim of this study was to investigate the levels of cytokines in placenta-derived mesenchymal stem cells (MSCs) in normal pregnancies and those with pre-eclampsia.
MATERIALS AND METHODS: C5a, CD40 Ligand, G-CSF, GM-CSF, GROalpha, I-309, sICAM-1, IFN-gamma, IL-1alpha, IL-1beta, IL-1ra, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-13, IL-16, IL-17, IL-17E, IL-23, IL-27, IL-32alpha, IP-10, I-TAC, MCP-1, MIF, MIP-1alpha, MIP-1beta, Serpin E1, RANTES, SDF-1, TNFalpha, and sTREM-1 were measured in mesenchymal stem cells using the human cytokine array panel A. The soluble intracellular adhesion molecule-1 (sICAM-1), stromal-derived factor-1 (SDF-1) and monocyte chemotactic protein-1 (MCP-1) were measured by real-time PCR and confirmed by Western blot analysis.
RESULTS: MSCs derived from the deciduas of normal pregnancies had significantly elevated levels of sICAM (p=0.000) and SDF-1 (p=0.011), compared to the pregnancies with pre-eclampsia. The level of MCP-1 in the decidua-derived MSCs was not significantly different. No significant difference was observed between normal and pre-eclamptic pregnancies for the amnion-derived MSCs.
CONCLUSIONS: The decreased levels of sICAM and SDF-1 found in the decidua-derived MSCs from pre-eclamptic pregnancies might be associated with some of the immunological alterations in pre-eclampsia. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19819721     DOI: 10.1016/j.cyto.2009.08.013

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  23 in total

Review 1.  Innate immunity, decidual cells, and preeclampsia.

Authors:  Chang-Ching Yeh; Kuan-Chong Chao; S Joseph Huang
Journal:  Reprod Sci       Date:  2012-07-18       Impact factor: 3.060

2.  Impaired Angiogenic Potential of Human Placental Mesenchymal Stromal Cells in Intrauterine Growth Restriction.

Authors:  Chiara Mandò; Paola Razini; Chiara Novielli; Gaia Maria Anelli; Marzia Belicchi; Silvia Erratico; Stefania Banfi; Mirella Meregalli; Alessandro Tavelli; Marco Baccarin; Alessandro Rolfo; Silvia Motta; Yvan Torrente; Irene Cetin
Journal:  Stem Cells Transl Med       Date:  2016-03-08       Impact factor: 6.940

3.  Cytokine dysregulation in early- and late-term placentas from feline immunodeficiency virus (FIV)-infected cats.

Authors:  Veronica L Scott; Crystal E Boudreaux; Nikki N Lockett; Brittany T Clay; Karen S Coats
Journal:  Am J Reprod Immunol       Date:  2010-09-06       Impact factor: 3.886

4.  Aspirin-Mediated Reset of Preeclamptic Placental Stem Cell Transcriptome - Implication for Stabilized Placental Function.

Authors:  Matthew P Romagano; Lauren S Sherman; Bobak Shadpoor; Markos El-Far; Sami Souayah; Sri Harika Pamarthi; Joshua Kra; Anupama Hood-Nehra; Jean-Pierre Etchegaray; Shauna F Williams; Pranela Rameshwar
Journal:  Stem Cell Rev Rep       Date:  2022-07-31       Impact factor: 6.692

5.  TLR4 Modulates Senescence and Paracrine Action in Placental Mesenchymal Stem Cells via Inhibiting Hedgehog Signaling Pathway in Preeclampsia.

Authors:  Yanqi Zhong; Yang Zhang; Weifang Liu; Yin Zhao; Li Zou; Xiaoxia Liu
Journal:  Oxid Med Cell Longev       Date:  2022-06-14       Impact factor: 7.310

6.  Low-dose aspirin treatment enhances the adhesion of preeclamptic decidual mesenchymal stem/stromal cells and reduces their production of pro-inflammatory cytokines.

Authors:  Ramin Khanabdali; Aida Shakouri-Motlagh; Sarah Wilkinson; Padma Murthi; Harry M Georgiou; Shaun P Brennecke; Bill Kalionis
Journal:  J Mol Med (Berl)       Date:  2018-10-01       Impact factor: 4.599

7.  High aminopeptidase N/CD13 levels characterize human amniotic mesenchymal stem cells and drive their increased adipogenic potential in obese women.

Authors:  Laura Iaffaldano; Carmela Nardelli; Maddalena Raia; Elisabetta Mariotti; Maddalena Ferrigno; Filomena Quaglia; Giuseppe Labruna; Valentina Capobianco; Angela Capone; Giuseppe Maria Maruotti; Lucio Pastore; Rosa Di Noto; Pasquale Martinelli; Lucia Sacchetti; Luigi Del Vecchio
Journal:  Stem Cells Dev       Date:  2013-04-23       Impact factor: 3.272

Review 8.  Emerging Therapeutic Potential of Mesenchymal Stem/Stromal Cells in Preeclampsia.

Authors:  S Suvakov; C Richards; V Nikolic; T Simic; K McGrath; A Krasnodembskaya; L McClements
Journal:  Curr Hypertens Rep       Date:  2020-04-14       Impact factor: 5.369

Review 9.  Possible roles of proinflammatory and chemoattractive cytokines produced by human fetal membrane cells in the pathology of adverse pregnancy outcomes associated with influenza virus infection.

Authors:  Noboru Uchide; Kunio Ohyama; Toshio Bessho; Makoto Takeichi; Hiroo Toyoda
Journal:  Mediators Inflamm       Date:  2012-07-31       Impact factor: 4.711

10.  Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: new insights into the etiopathogenesis of preeclampsia.

Authors:  Alessandro Rolfo; Domenica Giuffrida; Anna Maria Nuzzo; Daniele Pierobon; Simona Cardaropoli; Ettore Piccoli; Mirella Giovarelli; Tullia Todros
Journal:  PLoS One       Date:  2013-03-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.